Study of the Safety and Efficacy of Tropicamide Thin Films to Reduce Hypersalivation in Parkinson's Patients
Phase 2
Completed
- Conditions
- Sialorrhea (Excessive Drooling)
- Interventions
- Drug: NH004 Placebo
- First Posted Date
- 2013-05-01
- Last Posted Date
- 2015-12-10
- Lead Sponsor
- NeuroHealing Pharmaceuticals Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT01844648
- Locations
- 🇫🇷
Hôpital de la Salpêtrière, Paris, Cedrex 13, France
🇫🇷Hôpital Paul de Viguier, Toulouse, Cedrex 9, France
🇫🇷Hôpital Haut Lévêque, Bordeaux, Pessac, France
Safety and Efficacy Study of NH004 Films for Relief of Sialorrhea Symptoms in Parkinson's Disease Patients
Phase 2
Completed
- Conditions
- Sialorrhea Secondary to Parkinson's Disease
- Interventions
- First Posted Date
- 2008-09-29
- Last Posted Date
- 2015-10-12
- Lead Sponsor
- NeuroHealing Pharmaceuticals Inc.
- Target Recruit Count
- 19
- Registration Number
- NCT00761137
- Locations
- 🇦🇷
FLENI Hospital, Buenos Aires, Argentina
Efficacy Study of NH001 in Vegetative State & Minimally Conscious State Following a Traumatic Brain Injury
- First Posted Date
- 2008-09-29
- Last Posted Date
- 2017-03-31
- Lead Sponsor
- NeuroHealing Pharmaceuticals Inc.
- Target Recruit Count
- 76
- Registration Number
- NCT00761228
- Locations
- 🇺🇸
Spaulding Rehabilitation Hospital, Boston, Massachusetts, United States